PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan

This study aimed to evaluate genotype-phenotype correlations of Parkinson's disease (PD) patients with phospholipase A2 group V (PLA2G6) variants. We analyzed the DNA of 798 patients with PD, including 78 PD patients reported previously, and 336 in-house controls. We screened the exons and exon-intron boundaries of PLA2G6 using the Ion Torrent system and Sanger method. We identified 21 patients with 18 rare variants, such that 1, 9, and 11 patients were homozygous, heterozygous, and compound heterozygous, respectively, with respect to PLA2G6 variants. The allele frequency was approximately equal between patients with familial PD and those with sporadic PD. The PLA2G6 variants detected frequently were identified in the early-onset sporadic PD group. Patients who were homozygous for a variant showed more severe symptoms than those who were heterozygous for the variant. The most common variant was p.R635Q in our cohort, which was considered a risk variant for PD. Thus, the variants of PLA2G6 may play a role in familial PD and early-onset sporadic PD. (C) 2020 Elsevier Inc. All rights reserved.

Automated summary

This study evaluated the genotype-phenotype correlations of PD patients with PLA2G6 variants, discovering that these variants may play a role in familial PD and early-onset sporadic PD. Homozygous patients showed more severe symptoms, and p.R635Q was considered a risk variant for PD.